Geron (GERN) Other Working Capital Changes (2015 - 2017)
Geron's (GERN) quarterly Other Working Capital Changes came in at -$974000.0 in Q2 2026, down 89.13% year-over-year from -$9.0 million in Q2 2025, and down 143.6% quarter-over-quarter from $2.2 million in Q1 2026.
Analysis
Geron (GERN) Other Working Capital Changes (2015 - 2017) Analysis & Trends
Geron has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$974000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes fell 89.13% year-over-year to -$974000.0; the TTM figure through Jun 2026 stood at -$709000.0 (up 16.69% YoY), while the FY2025 annual figure was -$796000.0, down 11.33% from the prior year.
- Other Working Capital Changes came in at -$974000.0 for Q2 2026 at Geron, down from $2.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $16.1 million in Q3 2023 to a low of -$14.3 million in Q4 2023.
- Average Other Working Capital Changes over 3 years is $574222.2, with a median of $95000.0 recorded in 2015.
- The largest YoY upside for Other Working Capital Changes was 3534.9% in 2016 against a maximum downside of 955.79% in 2016.
- Over 4 years, Other Working Capital Changes stood at -$14.3 million in 2023, then soared by 82.16% to -$2.6 million in 2024, then soared by 75.4% to -$629000.0 in 2025, then slumped by 54.85% to -$974000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$974000.0 in Q2 2026, $2.2 million in Q1 2026, and -$629000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | -5.55 Mn |
| Sep 30, 2017 | -5.55 Mn |
| Jun 30, 2017 | -49,000.00 |
| Jun 30, 2017 | -49,000.00 |
| Mar 31, 2017 | 6.00 Mn |
| Mar 31, 2017 | 6.00 Mn |
| Sep 30, 2016 | 5.42 Mn |
| Sep 30, 2016 | 5.42 Mn |
| Jun 30, 2016 | -206,000.00 |
| Jun 30, 2016 | -206,000.00 |
| Mar 31, 2016 | -813,000.00 |
| Mar 31, 2016 | -813,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Jun 30, 2015 | 126,000.00 |
| Jun 30, 2015 | 126,000.00 |
| Mar 31, 2015 | 95,000.00 |
| Mar 31, 2015 | 95,000.00 |